Home
Resources
Publications
Identification of Eph Receptor Signaling as a Regulator of Autophagy and a Therapeutic Target in Colorectal Carcinoma

Identification of Eph Receptor Signaling as a Regulator of Autophagy and a Therapeutic Target in Colorectal Carcinoma

Michael DiPrima, Dunrui Wang, Alix Tröster, Dragan Maric, Nekane Terrades-Garcia, Taekyu Ha, Hyeongil Kwak, David Sanchez-Martin, Denis Kudlinzki, Harald Schwalbe, Giovanna Tosato

Mol Oncol. 2019 Nov;13(11):2441-2459.

PMID: 31545551

Abstract:

Advanced colorectal carcinoma is currently incurable, and new therapies are urgently needed. We report that phosphotyrosine-dependent Eph receptor signaling sustains colorectal carcinoma cell survival, thereby uncovering a survival pathway active in colorectal carcinoma cells. We find that genetic and biochemical inhibition of Eph tyrosine kinase activity or depletion of the Eph ligand EphrinB2 reproducibly induces colorectal carcinoma cell death by autophagy. Spautin and 3-methyladenine, inhibitors of early steps in the autophagic pathway, significantly reduce autophagy-mediated cell death that follows inhibition of phosphotyrosine-dependent Eph signaling in colorectal cancer cells. A small-molecule inhibitor of the Eph kinase, NVP-BHG712 or its regioisomer NVP-Iso, reduces human colorectal cancer cell growth in vitro and tumor growth in mice. Colorectal cancers express the EphrinB ligand and its Eph receptors at significantly higher levels than numerous other cancer types, supporting Eph signaling inhibition as a potential new strategy for the broad treatment of colorectal carcinoma.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP940310850	NVP-BHG712		940310-85-0	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: